Share Price and Basic Stock Data
Last Updated: February 9, 2026, 8:41 pm
| PEG Ratio | 13.17 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Galaxy Surfactants Ltd operates in the oil drilling and exploration sector, with a market capitalization of ₹6,429 Cr. The company’s stock price stood at ₹1,805. Revenue from operations has shown a marked increase, recording ₹4,462 Cr in FY 2023, up from ₹3,684 Cr in FY 2022. The trailing twelve months (TTM) figure for revenue reached ₹4,791 Cr. Quarterly sales trends indicate fluctuations, with a peak of ₹1,326 Cr in September 2025, while the lowest was ₹980 Cr in March 2023. The overall revenue trajectory suggests a recovery following a dip in FY 2024, where sales declined to ₹3,792 Cr. The consistent growth over the past few quarters reflects resilience in a challenging economic environment and strong demand for surfactants and specialty chemicals, critical to various industries.
Profitability and Efficiency Metrics
Galaxy Surfactants reported a net profit of ₹286 Cr for FY 2025, with an earnings per share (EPS) of ₹86.00. The company’s operating profit margin (OPM) stood at 11% for FY 2025, slightly lower than the 12% recorded in FY 2024. Meanwhile, the return on equity (ROE) was 12.90%, indicating efficient use of shareholder funds. The interest coverage ratio (ICR) of 26.50x signifies robust capacity to meet interest obligations, which is significantly higher than sector averages. However, the decline in net profit margins from 8.57% in FY 2023 to 7.21% in FY 2025 raises concerns about cost management and pricing power. Additionally, the cash conversion cycle (CCC) of 73 days is on the higher side compared to industry norms, potentially indicating inefficiencies in working capital management.
Balance Sheet Strength and Financial Ratios
As of September 2025, Galaxy Surfactants boasts total assets of ₹3,778 Cr, with reserves amounting to ₹2,499 Cr and borrowings of ₹268 Cr. The low debt-to-equity ratio of 0.06 underscores a conservative capital structure, providing financial stability and lower financial risk. The price-to-book value (P/BV) ratio stands at 3.08x, indicating a premium valuation compared to its book value of ₹666.44 per share. The current ratio of 2.14 suggests a strong liquidity position, enabling the company to cover its short-term liabilities comfortably. However, the decline in overall liquidity ratios compared to previous years may warrant monitoring. The inventory turnover ratio of 6.60x indicates effective inventory management, although it remains essential for the company to maintain this efficiency amidst fluctuating demand.
Shareholding Pattern and Investor Confidence
Galaxy Surfactants’ shareholding pattern reveals a strong promoter holding of 70.92%, indicating substantial management control and alignment with shareholder interests. Foreign institutional investors (FIIs) hold 4.21% of the company, while domestic institutional investors (DIIs) account for 12.90%. The public shareholding stands at 11.96%, reflecting a stable base of retail investors. The total number of shareholders decreased to 49,547 by September 2025, suggesting a potential consolidation in ownership. Despite the high promoter stake, the limited FII participation may imply a cautious approach from foreign investors towards the sector. However, the consistent dividend payout ratio of approximately 20.93% for FY 2025 reflects a commitment to returning value to shareholders, which could enhance investor confidence going forward.
Outlook, Risks, and Final Insight
Looking ahead, Galaxy Surfactants faces both opportunities and challenges. The company’s strong operational metrics, coupled with a low debt profile, position it well for growth in a recovering economic landscape. However, the declining profitability margins and potential inefficiencies in working capital management pose risks that need addressing. Additionally, external factors such as fluctuations in raw material prices and regulatory changes in the oil sector could impact profitability. The company’s ability to sustain its growth trajectory will depend on its strategic initiatives to enhance operational efficiency and manage costs effectively. Should it successfully navigate these challenges, Galaxy Surfactants may solidify its position as a leader in the surfactants market, capitalizing on the growing demand for sustainable and innovative chemical solutions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Natural Resources Ltd | 1,305 Cr. | 102 | 114/17.6 | 821 | 14.1 | 0.00 % | 0.56 % | 2.87 % | 10.0 |
| Dolphin Offshore Enterprises (India) Ltd | 1,721 Cr. | 428 | 506/200 | 34.0 | 75.5 | 0.00 % | 14.7 % | 18.7 % | 1.00 |
| Deep Energy Resources Ltd | 999 Cr. | 312 | / | 694 | 121 | 0.00 % | 0.39 % | 0.35 % | 10.0 |
| Selan Explorations Technology Ltd | 881 Cr. | 580 | 969/475 | 13.4 | 309 | 0.00 % | 22.8 % | 17.2 % | 10.0 |
| Oil India Ltd | 79,704 Cr. | 490 | 524/322 | 13.3 | 346 | 2.35 % | 12.9 % | 13.3 % | 10.0 |
| Industry Average | 36,099.92 Cr | 409.75 | 154.25 | 600.59 | 0.98% | 10.56% | 9.87% | 6.85 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,232 | 1,085 | 980 | 942 | 983 | 940 | 929 | 974 | 1,063 | 1,042 | 1,145 | 1,278 | 1,326 |
| Expenses | 1,100 | 931 | 845 | 819 | 858 | 828 | 827 | 850 | 935 | 936 | 1,018 | 1,154 | 1,216 |
| Operating Profit | 132 | 154 | 135 | 123 | 125 | 112 | 102 | 124 | 128 | 106 | 127 | 124 | 110 |
| OPM % | 11% | 14% | 14% | 13% | 13% | 12% | 11% | 13% | 12% | 10% | 11% | 10% | 8% |
| Other Income | 1 | 4 | 7 | 2 | 3 | 6 | 24 | 5 | 9 | 4 | 8 | 11 | 6 |
| Interest | 6 | 6 | 6 | 6 | 5 | 6 | 5 | 4 | 4 | 5 | 6 | 7 | 7 |
| Depreciation | 20 | 22 | 23 | 24 | 25 | 25 | 26 | 27 | 28 | 28 | 28 | 29 | 30 |
| Profit before tax | 107 | 131 | 113 | 96 | 98 | 88 | 94 | 99 | 104 | 77 | 100 | 99 | 79 |
| Tax % | 21% | 19% | 20% | 22% | 21% | 19% | 18% | 19% | 19% | 16% | 24% | 20% | 16% |
| Net Profit | 84 | 106 | 91 | 75 | 77 | 71 | 78 | 80 | 85 | 65 | 76 | 79 | 66 |
| EPS in Rs | 23.66 | 29.96 | 25.53 | 21.20 | 21.84 | 20.13 | 21.86 | 22.48 | 23.89 | 18.22 | 21.40 | 22.42 | 18.75 |
Last Updated: January 12, 2026, 9:16 am
Below is a detailed analysis of the quarterly data for Galaxy Surfactants Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 1,326.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,278.00 Cr. (Jun 2025) to 1,326.00 Cr., marking an increase of 48.00 Cr..
- For Expenses, as of Sep 2025, the value is 1,216.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,154.00 Cr. (Jun 2025) to 1,216.00 Cr., marking an increase of 62.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 110.00 Cr.. The value appears to be declining and may need further review. It has decreased from 124.00 Cr. (Jun 2025) to 110.00 Cr., marking a decrease of 14.00 Cr..
- For OPM %, as of Sep 2025, the value is 8.00%. The value appears to be declining and may need further review. It has decreased from 10.00% (Jun 2025) to 8.00%, marking a decrease of 2.00%.
- For Other Income, as of Sep 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Jun 2025) to 6.00 Cr., marking a decrease of 5.00 Cr..
- For Interest, as of Sep 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 7.00 Cr..
- For Depreciation, as of Sep 2025, the value is 30.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 29.00 Cr. (Jun 2025) to 30.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 79.00 Cr.. The value appears to be declining and may need further review. It has decreased from 99.00 Cr. (Jun 2025) to 79.00 Cr., marking a decrease of 20.00 Cr..
- For Tax %, as of Sep 2025, the value is 16.00%. The value appears to be improving (decreasing) as expected. It has decreased from 20.00% (Jun 2025) to 16.00%, marking a decrease of 4.00%.
- For Net Profit, as of Sep 2025, the value is 66.00 Cr.. The value appears to be declining and may need further review. It has decreased from 79.00 Cr. (Jun 2025) to 66.00 Cr., marking a decrease of 13.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 18.75. The value appears to be declining and may need further review. It has decreased from 22.42 (Jun 2025) to 18.75, marking a decrease of 3.67.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:21 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,870 | 1,799 | 2,158 | 2,432 | 2,761 | 2,595 | 2,782 | 3,684 | 4,462 | 3,792 | 4,221 | 4,791 |
| Expenses | 1,681 | 1,563 | 1,886 | 2,144 | 2,408 | 2,226 | 2,334 | 3,284 | 3,894 | 3,330 | 3,737 | 4,324 |
| Operating Profit | 190 | 236 | 271 | 288 | 353 | 369 | 449 | 401 | 568 | 462 | 484 | 467 |
| OPM % | 10% | 13% | 13% | 12% | 13% | 14% | 16% | 11% | 13% | 12% | 11% | 10% |
| Other Income | 2 | 6 | 10 | 10 | 5 | 6 | 11 | 13 | 10 | 35 | 26 | 29 |
| Interest | 34 | 34 | 27 | 31 | 30 | 24 | 13 | 13 | 22 | 22 | 19 | 25 |
| Depreciation | 45 | 45 | 47 | 49 | 51 | 62 | 74 | 71 | 83 | 100 | 110 | 115 |
| Profit before tax | 112 | 163 | 207 | 219 | 277 | 289 | 372 | 329 | 473 | 375 | 380 | 355 |
| Tax % | 40% | 37% | 29% | 28% | 31% | 20% | 19% | 20% | 19% | 20% | 20% | |
| Net Profit | 67 | 103 | 148 | 158 | 191 | 230 | 302 | 263 | 381 | 301 | 305 | 286 |
| EPS in Rs | 19.03 | 28.97 | 41.64 | 44.57 | 53.87 | 64.99 | 85.22 | 74.12 | 107.46 | 85.03 | 86.00 | 80.79 |
| Dividend Payout % | 21% | 31% | 14% | 16% | 15% | 22% | 21% | 24% | 20% | 26% | 5% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 53.73% | 43.69% | 6.76% | 20.89% | 20.42% | 31.30% | -12.91% | 44.87% | -21.00% | 1.33% |
| Change in YoY Net Profit Growth (%) | 0.00% | -10.04% | -36.93% | 14.13% | -0.47% | 10.89% | -44.22% | 57.78% | -65.86% | 22.33% |
Galaxy Surfactants Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 10% |
| 3 Years: | 5% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 6% |
| 3 Years: | 5% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | 6% |
| 3 Years: | -10% |
| 1 Year: | -19% |
| Return on Equity | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 18% |
| 3 Years: | 16% |
| Last Year: | 13% |
Last Updated: September 5, 2025, 4:25 am
Balance Sheet
Last Updated: December 4, 2025, 1:15 am
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 | 35 |
| Reserves | 342 | 412 | 539 | 683 | 841 | 1,032 | 1,266 | 1,539 | 1,847 | 2,144 | 2,327 | 2,499 |
| Borrowings | 451 | 412 | 393 | 348 | 298 | 396 | 289 | 421 | 327 | 187 | 210 | 268 |
| Other Liabilities | 231 | 250 | 315 | 385 | 389 | 348 | 458 | 602 | 518 | 539 | 877 | 975 |
| Total Liabilities | 1,060 | 1,109 | 1,283 | 1,452 | 1,563 | 1,812 | 2,049 | 2,597 | 2,728 | 2,906 | 3,450 | 3,778 |
| Fixed Assets | 459 | 436 | 456 | 447 | 519 | 748 | 712 | 760 | 923 | 973 | 1,030 | 1,029 |
| CWIP | 7 | 51 | 10 | 25 | 83 | 66 | 124 | 205 | 139 | 158 | 262 | 290 |
| Investments | 0 | 0 | 0 | 0 | 0 | 6 | 43 | 0 | 0 | 198 | 299 | 385 |
| Other Assets | 594 | 623 | 817 | 980 | 962 | 992 | 1,170 | 1,630 | 1,665 | 1,576 | 1,859 | 2,074 |
| Total Assets | 1,060 | 1,109 | 1,283 | 1,452 | 1,563 | 1,812 | 2,049 | 2,597 | 2,728 | 2,906 | 3,450 | 3,778 |
Below is a detailed analysis of the balance sheet data for Galaxy Surfactants Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 35.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 35.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,499.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,327.00 Cr. (Mar 2025) to 2,499.00 Cr., marking an increase of 172.00 Cr..
- For Borrowings, as of Sep 2025, the value is 268.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 210.00 Cr. (Mar 2025) to 268.00 Cr., marking an increase of 58.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 975.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 877.00 Cr. (Mar 2025) to 975.00 Cr., marking an increase of 98.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 3,778.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,450.00 Cr. (Mar 2025) to 3,778.00 Cr., marking an increase of 328.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,029.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,030.00 Cr. (Mar 2025) to 1,029.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 290.00 Cr.. The value appears strong and on an upward trend. It has increased from 262.00 Cr. (Mar 2025) to 290.00 Cr., marking an increase of 28.00 Cr..
- For Investments, as of Sep 2025, the value is 385.00 Cr.. The value appears strong and on an upward trend. It has increased from 299.00 Cr. (Mar 2025) to 385.00 Cr., marking an increase of 86.00 Cr..
- For Other Assets, as of Sep 2025, the value is 2,074.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,859.00 Cr. (Mar 2025) to 2,074.00 Cr., marking an increase of 215.00 Cr..
- For Total Assets, as of Sep 2025, the value is 3,778.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,450.00 Cr. (Mar 2025) to 3,778.00 Cr., marking an increase of 328.00 Cr..
Notably, the Reserves (2,499.00 Cr.) exceed the Borrowings (268.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -261.00 | -176.00 | -122.00 | -60.00 | 55.00 | -27.00 | 160.00 | -20.00 | 241.00 | 275.00 | 274.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 43 | 51 | 59 | 63 | 56 | 62 | 62 | 63 | 50 | 57 | 59 |
| Inventory Days | 68 | 72 | 79 | 75 | 68 | 72 | 91 | 103 | 78 | 82 | 95 |
| Days Payable | 50 | 59 | 63 | 71 | 59 | 60 | 80 | 75 | 52 | 66 | 81 |
| Cash Conversion Cycle | 61 | 64 | 75 | 67 | 65 | 73 | 72 | 91 | 76 | 73 | 73 |
| Working Capital Days | 4 | 27 | 31 | 39 | 41 | 43 | 50 | 63 | 55 | 64 | 52 |
| ROCE % | 23% | 26% | 25% | 28% | 24% | 25% | 19% | 24% | 17% | 16% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Contra Fund | 51,993,788 | 1.79 | 895.13 | 41,173,788 | 2025-12-08 04:54:22 | 26.28% |
| SBI Balanced Advantage Fund | 46,405,618 | 2 | 798.92 | 53,293,368 | 2025-12-08 04:54:22 | -12.92% |
| SBI Energy Opportunities Fund | 35,634,819 | 6.72 | 613.49 | N/A | N/A | N/A |
| HDFC Balanced Advantage Fund | 34,000,000 | 0.54 | 585.34 | N/A | N/A | N/A |
| SBI PSU Fund | 29,150,000 | 8.63 | 501.85 | 25,750,000 | 2026-01-26 03:21:03 | 13.2% |
| SBI Large Cap Fund | 29,000,000 | 0.89 | 499.26 | N/A | N/A | N/A |
| SBI ELSS Tax Saver Fund | 26,493,555 | 1.4 | 456.11 | N/A | N/A | N/A |
| Aditya Birla Sun Life PSU Equity Fund | 18,291,648 | 5.58 | 314.91 | N/A | N/A | N/A |
| Kotak Flexicap Fund | 15,500,000 | 0.47 | 266.85 | 17,000,000 | 2025-12-15 00:55:52 | -8.82% |
| Kotak Multicap Fund | 15,500,000 | 1.16 | 266.85 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 86.00 | 85.03 | 107.46 | 74.12 | 85.22 |
| Diluted EPS (Rs.) | 86.00 | 85.03 | 107.46 | 74.12 | 85.22 |
| Cash EPS (Rs.) | 117.14 | 113.20 | 131.02 | 94.17 | 106.09 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 666.44 | 614.74 | 531.04 | 444.10 | 367.11 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 666.44 | 614.74 | 531.04 | 444.10 | 367.11 |
| Revenue From Operations / Share (Rs.) | 1191.44 | 1070.35 | 1253.95 | 1039.69 | 785.35 |
| PBDIT / Share (Rs.) | 143.88 | 140.39 | 163.08 | 116.56 | 129.67 |
| PBIT / Share (Rs.) | 112.75 | 112.23 | 139.53 | 96.52 | 108.81 |
| PBT / Share (Rs.) | 107.32 | 105.92 | 133.41 | 92.89 | 105.03 |
| Net Profit / Share (Rs.) | 86.01 | 85.04 | 107.47 | 74.13 | 85.23 |
| NP After MI And SOA / Share (Rs.) | 86.01 | 85.04 | 107.47 | 74.13 | 85.23 |
| PBDIT Margin (%) | 12.07 | 13.11 | 13.00 | 11.21 | 16.51 |
| PBIT Margin (%) | 9.46 | 10.48 | 11.12 | 9.28 | 13.85 |
| PBT Margin (%) | 9.00 | 9.89 | 10.63 | 8.93 | 13.37 |
| Net Profit Margin (%) | 7.21 | 7.94 | 8.57 | 7.12 | 10.85 |
| NP After MI And SOA Margin (%) | 7.21 | 7.94 | 8.57 | 7.12 | 10.85 |
| Return on Networth / Equity (%) | 12.90 | 13.83 | 20.23 | 16.69 | 23.21 |
| Return on Capital Employeed (%) | 16.09 | 17.21 | 24.07 | 19.71 | 26.98 |
| Return On Assets (%) | 8.80 | 10.34 | 13.93 | 10.10 | 14.74 |
| Long Term Debt / Equity (X) | 0.01 | 0.02 | 0.04 | 0.05 | 0.05 |
| Total Debt / Equity (X) | 0.06 | 0.06 | 0.14 | 0.23 | 0.18 |
| Asset Turnover Ratio (%) | 1.32 | 1.34 | 1.42 | 1.34 | 1.09 |
| Current Ratio (X) | 2.14 | 2.82 | 2.36 | 1.81 | 1.87 |
| Quick Ratio (X) | 1.40 | 1.90 | 1.41 | 0.99 | 1.18 |
| Inventory Turnover Ratio (X) | 6.60 | 4.15 | 4.30 | 4.78 | 4.19 |
| Dividend Payout Ratio (NP) (%) | 20.93 | 4.70 | 33.50 | 5.39 | 16.42 |
| Dividend Payout Ratio (CP) (%) | 15.36 | 3.53 | 27.48 | 4.24 | 13.19 |
| Earning Retention Ratio (%) | 79.07 | 95.30 | 66.50 | 94.61 | 83.58 |
| Cash Earning Retention Ratio (%) | 84.64 | 96.47 | 72.52 | 95.76 | 86.81 |
| Interest Coverage Ratio (X) | 26.50 | 22.22 | 26.64 | 32.16 | 34.25 |
| Interest Coverage Ratio (Post Tax) (X) | 16.84 | 14.46 | 18.56 | 21.45 | 23.51 |
| Enterprise Value (Cr.) | 7197.68 | 7937.75 | 8295.42 | 10453.78 | 9184.23 |
| EV / Net Operating Revenue (X) | 1.70 | 2.09 | 1.87 | 2.84 | 3.30 |
| EV / EBITDA (X) | 14.11 | 15.95 | 14.35 | 25.30 | 19.98 |
| MarketCap / Net Operating Revenue (X) | 1.72 | 2.12 | 1.86 | 2.76 | 3.25 |
| Retention Ratios (%) | 79.06 | 95.29 | 66.49 | 94.60 | 83.57 |
| Price / BV (X) | 3.08 | 3.69 | 4.39 | 6.45 | 6.96 |
| Price / Net Operating Revenue (X) | 1.72 | 2.12 | 1.86 | 2.76 | 3.25 |
| EarningsYield | 0.04 | 0.03 | 0.04 | 0.02 | 0.03 |
After reviewing the key financial ratios for Galaxy Surfactants Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 86.00. This value is within the healthy range. It has increased from 85.03 (Mar 24) to 86.00, marking an increase of 0.97.
- For Diluted EPS (Rs.), as of Mar 25, the value is 86.00. This value is within the healthy range. It has increased from 85.03 (Mar 24) to 86.00, marking an increase of 0.97.
- For Cash EPS (Rs.), as of Mar 25, the value is 117.14. This value is within the healthy range. It has increased from 113.20 (Mar 24) to 117.14, marking an increase of 3.94.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 666.44. It has increased from 614.74 (Mar 24) to 666.44, marking an increase of 51.70.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 666.44. It has increased from 614.74 (Mar 24) to 666.44, marking an increase of 51.70.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,191.44. It has increased from 1,070.35 (Mar 24) to 1,191.44, marking an increase of 121.09.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 143.88. This value is within the healthy range. It has increased from 140.39 (Mar 24) to 143.88, marking an increase of 3.49.
- For PBIT / Share (Rs.), as of Mar 25, the value is 112.75. This value is within the healthy range. It has increased from 112.23 (Mar 24) to 112.75, marking an increase of 0.52.
- For PBT / Share (Rs.), as of Mar 25, the value is 107.32. This value is within the healthy range. It has increased from 105.92 (Mar 24) to 107.32, marking an increase of 1.40.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 86.01. This value is within the healthy range. It has increased from 85.04 (Mar 24) to 86.01, marking an increase of 0.97.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 86.01. This value is within the healthy range. It has increased from 85.04 (Mar 24) to 86.01, marking an increase of 0.97.
- For PBDIT Margin (%), as of Mar 25, the value is 12.07. This value is within the healthy range. It has decreased from 13.11 (Mar 24) to 12.07, marking a decrease of 1.04.
- For PBIT Margin (%), as of Mar 25, the value is 9.46. This value is below the healthy minimum of 10. It has decreased from 10.48 (Mar 24) to 9.46, marking a decrease of 1.02.
- For PBT Margin (%), as of Mar 25, the value is 9.00. This value is below the healthy minimum of 10. It has decreased from 9.89 (Mar 24) to 9.00, marking a decrease of 0.89.
- For Net Profit Margin (%), as of Mar 25, the value is 7.21. This value is within the healthy range. It has decreased from 7.94 (Mar 24) to 7.21, marking a decrease of 0.73.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.21. This value is below the healthy minimum of 8. It has decreased from 7.94 (Mar 24) to 7.21, marking a decrease of 0.73.
- For Return on Networth / Equity (%), as of Mar 25, the value is 12.90. This value is below the healthy minimum of 15. It has decreased from 13.83 (Mar 24) to 12.90, marking a decrease of 0.93.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.09. This value is within the healthy range. It has decreased from 17.21 (Mar 24) to 16.09, marking a decrease of 1.12.
- For Return On Assets (%), as of Mar 25, the value is 8.80. This value is within the healthy range. It has decreased from 10.34 (Mar 24) to 8.80, marking a decrease of 1.54.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.06. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.06.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.32. It has decreased from 1.34 (Mar 24) to 1.32, marking a decrease of 0.02.
- For Current Ratio (X), as of Mar 25, the value is 2.14. This value is within the healthy range. It has decreased from 2.82 (Mar 24) to 2.14, marking a decrease of 0.68.
- For Quick Ratio (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has decreased from 1.90 (Mar 24) to 1.40, marking a decrease of 0.50.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 6.60. This value is within the healthy range. It has increased from 4.15 (Mar 24) to 6.60, marking an increase of 2.45.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 20.93. This value is within the healthy range. It has increased from 4.70 (Mar 24) to 20.93, marking an increase of 16.23.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 15.36. This value is below the healthy minimum of 20. It has increased from 3.53 (Mar 24) to 15.36, marking an increase of 11.83.
- For Earning Retention Ratio (%), as of Mar 25, the value is 79.07. This value exceeds the healthy maximum of 70. It has decreased from 95.30 (Mar 24) to 79.07, marking a decrease of 16.23.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 84.64. This value exceeds the healthy maximum of 70. It has decreased from 96.47 (Mar 24) to 84.64, marking a decrease of 11.83.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 26.50. This value is within the healthy range. It has increased from 22.22 (Mar 24) to 26.50, marking an increase of 4.28.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 16.84. This value is within the healthy range. It has increased from 14.46 (Mar 24) to 16.84, marking an increase of 2.38.
- For Enterprise Value (Cr.), as of Mar 25, the value is 7,197.68. It has decreased from 7,937.75 (Mar 24) to 7,197.68, marking a decrease of 740.07.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.70. This value is within the healthy range. It has decreased from 2.09 (Mar 24) to 1.70, marking a decrease of 0.39.
- For EV / EBITDA (X), as of Mar 25, the value is 14.11. This value is within the healthy range. It has decreased from 15.95 (Mar 24) to 14.11, marking a decrease of 1.84.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has decreased from 2.12 (Mar 24) to 1.72, marking a decrease of 0.40.
- For Retention Ratios (%), as of Mar 25, the value is 79.06. This value exceeds the healthy maximum of 70. It has decreased from 95.29 (Mar 24) to 79.06, marking a decrease of 16.23.
- For Price / BV (X), as of Mar 25, the value is 3.08. This value exceeds the healthy maximum of 3. It has decreased from 3.69 (Mar 24) to 3.08, marking a decrease of 0.61.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.72. This value is within the healthy range. It has decreased from 2.12 (Mar 24) to 1.72, marking a decrease of 0.40.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Galaxy Surfactants Ltd:
- Net Profit Margin: 7.21%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.09% (Industry Average ROCE: 10.56%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 12.9% (Industry Average ROE: 9.87%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 16.84
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.4
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 22.9 (Industry average Stock P/E: 154.25)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.06
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.21%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Gas Transmission/Marketing | GAIL Bhawan 16, Bhikaiji Cama Place, New Delhi Delhi 110066 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Sandeep Kumar Gupta | Chairman & Managing Director |
| Mr. Rakesh Kumar Jain | Director - Finance & CFO |
| Mr. Deepak Gupta | Director - Projects |
| Mr. Ayush Gupta | Director - Human Resources |
| Mr. Rajeev Kumar Singhal | Director - Business Development |
| Mr. Sanjay Kumar | Director - Marketing |
| Mr. Akhilesh Jain | Non Official Independent Director |
| Mr. Sanjay Kashyap | Non Official Independent Director |
| Mrs. Kangabam Inaocha Devi | Non Official Independent Director |
| Mr. Yajurvendra Anil Mahajan | Non Official Independent Director |
| Ms. Kamini Chauhan Ratan | Government Nominee Director |
| Mr. Kushagra Mittal | Government Nominee Director |
FAQ
What is the intrinsic value of Galaxy Surfactants Ltd?
Galaxy Surfactants Ltd's intrinsic value (as of 09 February 2026) is ₹1820.48 which is 1.91% lower the current market price of ₹1,856.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹6,570 Cr. market cap, FY2025-2026 high/low of ₹2,750/1,800, reserves of ₹2,499 Cr, and liabilities of ₹3,778 Cr.
What is the Market Cap of Galaxy Surfactants Ltd?
The Market Cap of Galaxy Surfactants Ltd is 6,570 Cr..
What is the current Stock Price of Galaxy Surfactants Ltd as on 09 February 2026?
The current stock price of Galaxy Surfactants Ltd as on 09 February 2026 is ₹1,856.
What is the High / Low of Galaxy Surfactants Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Galaxy Surfactants Ltd stocks is ₹2,750/1,800.
What is the Stock P/E of Galaxy Surfactants Ltd?
The Stock P/E of Galaxy Surfactants Ltd is 22.9.
What is the Book Value of Galaxy Surfactants Ltd?
The Book Value of Galaxy Surfactants Ltd is 715.
What is the Dividend Yield of Galaxy Surfactants Ltd?
The Dividend Yield of Galaxy Surfactants Ltd is 1.19 %.
What is the ROCE of Galaxy Surfactants Ltd?
The ROCE of Galaxy Surfactants Ltd is 16.2 %.
What is the ROE of Galaxy Surfactants Ltd?
The ROE of Galaxy Surfactants Ltd is 13.5 %.
What is the Face Value of Galaxy Surfactants Ltd?
The Face Value of Galaxy Surfactants Ltd is 10.0.
